Menu
Search
Home > Courses > Antiretroviral Pre-exposure Prophylaxis (PrEP) for HIV Prevention: Efficacy Trials and Planning for Results

Antiretroviral Pre-exposure Prophylaxis (PrEP) for HIV Prevention: Efficacy Trials and Planning for Results

Antiretroviral Pre-exposure Prophylaxis (PrEP) for HIV Prevention: Efficacy Trials and Planning for
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 3/23/2010
Review Date: 3/23/2010
Presenter
  • Connie Celum, MD, MPH
    Professor of Global Health and Medicine
    University of Washington
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Summarize the rationale, design and status of ongoing efficacy trials of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention.
  2. Discuss considerations for implementation if PrEP is shown to be efficacious and safe.
  3. Discuss remaining research questions about PrEP.
Presenter Bio
Connie Celum, MD, MPH
Connie Celum, MD is Professor of Global Health and Medicine at University of Washington and Director of the International Clinical Research Center in the Dept of Global Health. She received her medical school and internal medicine residency training at University of California San Francisco and infectious disease training and epidemiology training at University of Washington. Her research currently focuses on clinical trials of biomedical HIV prevention and combination HIV prevention strategies with the objective to find effective strategies to reduce HIV acquisition and transmission.
PRN Learning Modules